Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index‐2 (FI‐2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rider LG, 2003, Defining clinical improvement in adult and juvenile myositis, J Rheumatol, 30, 603
Huber AM, 2001, Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies, J Rheumatol, 28, 1106
Feldman BM, 1995, Measuring disability in juvenile dermatomyositis: validity of the Childhood Health Assessment Questionnaire, J Rheumatol, 22, 326
Alexanderson H, 2002, Development of the Myositis Activities Profile: validity and reliability of a self‐administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis, J Rheumatol, 29, 2386
Ruperto N, 2001, Cross‐cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries: review of the general methodology, Clin Exp Rheumatol, 19, S1
Hay EM, 1993, The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus, Q J Med, 86, 447
Symmons DP, 1988, Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus, Q J Med, 69, 927
Smith RL, 2004, Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops, J Rheumatol, 31, 1644
Landgraf JM, 1996, The CHQ user's manual
Martini A, 2001, Quality of life in juvenile idiopathic arthritis patients compared to healthy children, Clin Exp Rheumatol, 19, S1
Duffy CM, 1997, The Juvenile Arthritis Quality of Life Questionnaire: development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides, J Rheumatol, 24, 738
Mathiesen PR, 2010, Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients, Clin Exp Rheumatol, 28, 782
Stoll T, 1995, Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method, J Rheumatol, 22, 473
Josefson A, 1996, A functional index in myositis, J Rheumatol, 23, 1380
Alexanderson H, 2009, Patients with idiopathic inflammatory myopathies have low muscle endurance rather than low muscle strength, Arthritis Rheum, 60, S307
World Health Organization, 1999, International classification of impairment, disability and handicap: β‐2 draft, full version
Chock M, 2010, Quantitative assessment of disease severity in dermatomyositis, J Invest Dermatol, 130, S50
Goreshi R, 2010, Evaluation of reliability, validity, and responsiveness of the CDASI and CAT‐BM, Arthritis Rheum, 62, S381